US drug company Pfizer has penned a deal to allow its experimental Covid-19 treatment pill to be made and sold in 95 developing nations.
The deal with the UN-backed Medicines Patent Pool not-for-profit could make the treatment available to 53% of the world’s population.
But it excludes several countries that have had large Covid-19 outbreaks, including Brazil.
Pfizer says the pill lessens the risk of severe disease in vulnerable adults.